Synthesis, structure, anticancer, and antioxidant activity of para-xylyl linked bis-benzimidazolium salts and respective dinuclear Ag(I) N-heterocyclic carbene complexes (Part-II)

Medicinal Chemistry Research

Volumn 22, Issue 10, 2013, Pages 4663-4676

  Haque, Rosenani A ^a   Iqbal, Muhammad Adnan ^a   Asekunowo, Patrick ^a   Majid, A M S Abdul ^b   Khadeer Ahamed, Mohamed B ^b   Umar, Muhammad Ihtisham ^b   Al Rawi, Sawsan S ^b   Al Suede, Fouad Saleih R ^b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Ag NHC complexes; Antioxidant; Benzimidazole; Benzimidazolium salts; Human colon cancer (HCT 116); N Heterocyclic carbenes (NHCs)

Indexed keywords

1,4 BIS(N DECYLBENZIMIDAZOLYLMETHYL)BENZENE SILVER BIS(HEXAFLUOROPHOPSHATE) COMPLEX; 1,4 BIS(N NONYLBENZIMIDAZOLYLMETHYL)BENZENE SILVER BIS(HEXAFLUOROPHOPSHATE) COMPLEX; 1,4 BIS(N OCTYLBENZIMIDAZOLYLMETHYL)BENZENE SILVER BIS(HEXAFLUOROPHOPSHATE) COMPLEX; 3,3' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1 DECYL BENZIMIDAZOLIUM) DIBROMIDE; 3,3' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1 NONYL BENZIMIDAZOLIUM) DIBROMIDE; 3,3' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1 OCTYLBENZIMIDAZOLIUM)DIBROMIDE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; CARBENE; FLUOROURACIL; GALLIC ACID; SILVER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL STRAIN HCT116; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROGEN BOND; IC 50; IN VITRO STUDY;

EID: 84883462466     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0461-8     Document Type: Article

References (23)

1. Babizhayev M, Courbebaisse Y, Nicolay J-F, Semiletov Y (1998) Design and biological activity of imidazole-containing peptidomimetics with a broad-spectrum antioxidant activity. Lett Pept Sci 5(2-3):163-169
2. Baker MV, Brown DH, Haque RA, Skelton BW, White AH (2004) Dinuclear N-heterocyclic carbene complexes of silver(i), derived from imidazolium-linked cyclophanes. Dalton Trans 21:3756-3764
3. Baker MV, Brown DH, Haque RA, Skelton BW, White AH (2009) Silver(I) and mercury(II) complexes of meta- and para-xylyl linked bis(imidazol-2-ylidenes). J Incl Phenom Macrocycl Chem 65(1):97-109
4. Bansal Y, Silakari O (2012) The therapeutic journey of benzimidazoles: a review. Bioorg Med Chem 20(21):6208-6236
5. Bildstein B, Malaun M, Kopacka H, Wurst K, Mitterböck M, Ongania K-H, Opromolla G, Zanello P (1999) N, N′-Diferrocenyl-N-heterocyclic carbenes and their derivatives. Organometallics 18(21):4325-4336
6. Cole ER, Crank G, Salam-Sheikh A (1974) Antioxidant properties of benzimidazoles. J Agric Food Chem 22(5):918
7. Graham C (2005) The role of silver in wound healing. Br J Nutr 14(19):S22
8. Haque RA, Iqbal MA (2012a) Synthesis and characterization of ortho-xylyl linked bis-benzimidazolium salts. Asian J Chem 24(6):2625-2628
9. Haque RA, Iqbal MA (2012b) Synthesis and characterization of ortho-xylyl linked bis-benzimidazolium salts (Part-II). Asian J Chem 25(4):3049-3054
10. Haque RA, Iqbal MA, Hemamalini M, Fun H-K (2011) 3,3′-[1,2- Phenylenebis(methylene)]bis(1-heptylbenzimidazolium) dibromide monohydrate. Acta Crystallogr E 67(7):o1814-o1815
11. Haque RA, Ghdhayeb MZ, Budagumpi S, Salman AW, Khadeer Ahamed MB, Majid AMSA (2012a) Non-symmetrically substituted N-heterocyclic carbene-Ag(I) complexes of benzimidazol-2-ylidenes: synthesis, crystal structures, anticancer activity and transmetallation studies. Inorg Chim Acta 392:61-72
12. Haque RA, Iqbal MA, Ahmad SA, Chia TS, Fun H-K (2012b) 3,3′-[1,4-Phenylenebis(methylene)]bis(1-propylbenzimidazolium) dichloride dihydrate. Acta Crystallogr E 68(3):o845-o846
13. Haque RA, Iqbal MA, Budagumpi S, Hemamalini M, Fun H-K (2012c) 3,3′-[1,2-Phenylenebis(methylene)]bis(1-ethylbenzimidazolium) dibromide. Acta Crystallogr E 68(3):o573
14. Haque RA, Iqbal MA, Fun H-K, Arshad S (2012d) 3,3′-[1,2- Phenylenebis(methylene)]bis(1-octylbenzimidazolium) dibromide monohydrate. Acta Crystallogr E 68(4):o924-o925
15. Haque RA, Iqbal MA, Khadeer MB, Majeed AA, Abdul Hameed ZA (2012e) Design, synthesis and structural studies of meta-xylyl linked bis-benzimidazolium salts: potential anticancer agents against 'human colon cancer'. Chem Cent J 6(1):68
16. Haque RA, Iqbal MA, Rosli MM, Fun H-K (2012f) 3,3′-[1,2- Phenylenebis(methylene)]bis(1-ethyl-1H-benzimidazol-1-ium) bis(hexaflourophosphate). Acta Crystallogr E 68(6):o1635
17. Hranjec M, Starčević K, Pavelić SK, Lučin P, Pavelić K, Karminski Zamola G (2011) Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles. Eur J Med Chem 46(6):2274-2279
18. Iqbal MA, Haque RA, Ahamed MBK, Abdul MAMS, Al-Rawi S (2013) Synthesis and anticancer activity of para-xylyl linked bis-benzimidazolium salts and respective Ag(I) N-heterocyclic carbene complexes. Med Chem Res. doi: 10.1007/s00044-00012-00240-00046
19. Kascatan-Nebioglu A, Panzner MJ, Tessier CA, Cannon CL, Youngs WJ (2007) N-Heterocyclic carbene-silver complexes: a new class of antibiotics. Coord Chem Rev 251(5-6):884-895
20. Kim KS, Lee S, Lee YS, Jung SH, Park Y, Shin KH, Kim B-K (2003) Anti-oxidant activities of the extracts from the herbs of Artemisia apiacea. J Ethnopharmacol 85(1):69-72
21. Narasimhan B, Sharma D, Kumar P (2012) Benzimidazole: a medicinally important heterocyclic moiety. Med Chem Res 21(3):269-283
22. Starikova OV, Dolgushin GV, Larina LI, Ushakov PE, Komarova TN, Lopyrev TN (2003) Synthesis of 1,3-dialkylimidazolium and 1,3-dialkylbenzimidazolium salts. Russ J Org Chem 39(10):1467-1470
23. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW (2005) Colorectal cancer. The Lancet 365(9454):153-165